Life in the Fast Lane: Aducanumab and the Accelerated FDA Approval Process

<p>Joseph C. Osborne II, PharmD, @JOzempic describes the pharmacology of aducanumab, summarizes the clinical literature and approval process for aducanumab, and discusses stewardship considerations of aducanumab. </p> <p>Twitter: <a href='https://mobile.twitter.com/jozempic'>@JOzempic</a></p> <p>For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href='https://twitter.com/MayoPharmRes'>@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href='https://twitter.com/garrett_schramm'>@garrett_schramm</a> on Twitter!</p> <p>You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>